Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Children's Oncology Group
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
The First Affiliated Hospital of Soochow University
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kyowa Kirin Co., Ltd.
Beijing Tongren Hospital
OHSU Knight Cancer Institute
Sanofi
Therapeutic Advances in Childhood Leukemia Consortium
Eli Lilly and Company
Bristol-Myers Squibb
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
University of Washington